We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00741533
First Posted: August 26, 2008
Last Update Posted: November 18, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Chulalongkorn University
  Purpose
To study the quality of life of patients earlier diagnosed for cervical cancer and cervical intraepithelial neoplasia (CIN).

Condition
Quality of Life Cervical Cancer Cervical Intraepithelial Neoplasia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Enrollment: 172
Study Start Date: February 2008
Study Completion Date: July 2009
Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Detailed Description:
In Thailand, age standardized incidence is 20.9 per 100,000 women-year. Treatment-related survival gain are experienced by side-effect that may reduce quality of life (QoL). We therefore, study the quality of life of patients earlier diagnosed for cervical cancer patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cervical intraepithelial neoplasia (CIN) or cervical cancer patients
Criteria

Inclusion Criteria:

  • Thai patients
  • aged more than 15 years old.
  • Diagnosed of cervical intraepithelial neoplasia (CIN) or cervical cancer with pathological confirmation. If she has more than one diseases, the most severe will be considered as diagnosis.
  • Not suffered from confusion or reduced level of consciousness or unable to communicate.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00741533


Locations
Thailand
King Chulalongkorn Memorial Hospital
Patumwan, Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Merck Sharp & Dohme Corp.
Investigators
Principal Investigator: Surasak Taneepanichskul, MD. College of Public Health Sciences, Chulalongkorn University
  More Information

Responsible Party: Dean,College of Public Health Sciences, Chulalongkorn University., College of Public Health Sciences, Chulalongkorn University.
ClinicalTrials.gov Identifier: NCT00741533     History of Changes
Other Study ID Numbers: CPHS-01
First Submitted: August 25, 2008
First Posted: August 26, 2008
Last Update Posted: November 18, 2010
Last Verified: November 2010

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Carcinoma in Situ
Cervical Intraepithelial Neoplasia
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type